MUDr. Ilona Pavlisova s.r.o.
- Address
- lock Available on a paid plan
Respiratory Tract Diseases
The research at MUDr. Ilona Pavlisova s.r.o. focuses on chronic lung conditions such as Chronic Obstructive Pulmonary Disease (COPD), mild to moderate asthma, and refractory chronic cough, aiming to test new inhaled therapies that improve lung function and reduce disease flare‑ups.
- Evaluation of inhaled bronchodilator efficacy
- Strategies to lower COPD exacerbation rates
- Assessments of combination maintenance therapy
- Improvement of cough frequency and severity
By conducting these trials, the site seeks to expand treatment options and enhance quality of life for patients living with persistent respiratory diseases.
Immune System Phenomena
In addition to standard respiratory research, the centre investigates immune system mechanisms that drive airway inflammation, using biologic agents to explore novel ways of controlling disease activity in asthma and COPD.
- Targeted immune‑modulating therapies for COPD
- Biologic treatments addressing airway inflammation
- Cough reflex modulation through immune pathways
- Safety and tolerability profiling of new immune agents
These studies aim to broaden the therapeutic landscape by linking immune insights with practical interventions for chronic respiratory illnesses.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Chiesi Farmaceutici S.p.A.1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Chiesi Farmaceutici S.p.A.4trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in MUDr. Ilona Pavlisova s.r.o.
lock Showing 1 of 10 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2 study to evaluate the efficacy and safety of RPT193 in adults with moderate-to-severe T2-high asthma who are partially controlled on inhaled corticosteroid and long-acting beta 2 agonist therapy | Rapt Therapeutics Inc. | Phase II | Not Recruiting | Nov 2023 | Jun 2024 |
IMP list
lock Showing 1 of 15 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Beclometasone Dipropionate Anhydrous | 2 | Unknown | 2022-04-22 | 2026-04-13 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.